Senka
More about SenkaAffordable Japanese cleansing-focused skincare brand from Shiseido, famous for its Perfect Whip foam.
The story behind Senka Read the full story
Senka began in 2003 as Shiseido's answer to a simple problem: an affordable, everyday cleanser that felt better than its price suggested. The result, Perfect Whip, became a fixture in Japanese bathrooms, racking up years as one of the country's best-selling face washes on the strength of an unusually dense, soft foam built around silk-derived and hyaluronic ingredients. For most of its life Senka sat inside Shiseido's daily-necessities division, which is where the brand's quiet ubiquity was built. That changed in 2021, when Shiseido carved out its personal-care business into a new company, FineToday Holdings, backed by private-equity firm CVC; Senka moved over alongside stablemates like Tsubaki and Uno. FineToday itself changed hands again in 2026, when Bain Capital agreed to acquire it from CVC. Through all the corporate reshuffling, Senka's product identity has stayed remarkably stable: cleansers, makeup removers, and lotions aimed at the drugstore shopper who wants competence without a premium markup. Its credibility is the unglamorous kind, earned through years of repeat purchases rather than headline actives, and it remains a reliable, affordable staple rather than a treatment-led line.
- Founded
- 2003
- Origin
- Japan
- Parent company
- FineToday Holdings
- Heritage
- Established
- Type
- Drugstore
- Verdicts
- 0 Strong choice · 3 Good choice of 13 assessed
- Top-rated
- Senka Perfect Whip Acne Care
All Senka Products
More about Senka
Senka is a Japanese mass-market skincare brand created by Shiseido in 2003 and best known for its Perfect Whip foaming cleanser, long a top-selling face wash in Japan.
Since 2021 it has belonged to FineToday Holdings, the personal-care business carved out of Shiseido (acquired by Bain Capital from CVC in 2026), not Shiseido itself. Its reputation rests on decades of consistent drugstore performance and affordability rather than clinical-grade actives.